University Hospital Tübingen

University Hospital Tübingen (UKT) is a premier center of German university medicine, consistently ranked among the Top 5 hospitals in Germany by Focus Medical. Since its founding in 1805, the hospital has served as a bridge between historical medical tradition and futuristic clinical research. As one of Germany's elite "Excellence" universities, Tübingen is a global leader in translating laboratory discoveries into bedside therapies, particularly in neuroscience, oncology, and immunology. The university hospital, the region's largest employer, has about 11,200 full-time and part-time employees. The hospital was the first in Germany to receive KTQ certification, confirming the high quality and efficiency of its medical care. The reputation for innovation is anchored by its world-renowned neurology and neurosurgery departments. Tübingen researchers are pioneers in treating neurodegenerative diseases, recently receiving international acclaim and major prizes for developing genetically based drug therapies for severe early-childhood epilepsy and discovering risk factors for Parkinson's disease. In 2018, the team of neurologists was awarded the Eva Luise Kohler Research Prize for developing the first specific drug therapy for severe early epilepsy. The Hertie Institute for Clinical Brain Research, located on-site, ensures that University Hospital Tübingen remains at the absolute frontier of mapping the human brain and treating its most complex disorders. In oncology, Tübingen is a pioneer in women’s health, having established Germany’s first certified Breast Center. The hospital enjoys a world-class reputation for "Onco-surgery," specializing in high-precision interventions for ovarian, uterine, and cervical cancers. Furthermore, the iFIT Cluster of Excellence, the only oncology-focused excellence cluster in Germany, operates within the hospital to develop individualized immunotherapies and multiparametric imaging techniques, providing patients with access to clinical trials that are not otherwise available. University Hospital Tübingen's commitment to "Maximum Care" is further evidenced by its status as a leading Transplant Center, which performs complex organ transplants with a multidisciplinary team of surgeons and immunologists. The Department of Diabetology is a national reference point that recently provided groundbreaking insights into the brain's role in obesity and type 2 diabetes. This high-tech environment is balanced by a strong focus on the next generation; as the region’s largest provider of apprenticeships and medical training, UKT ensures that the highest standards of care are carried forward by thousands of young professionals trained in the "Tübingen Spirit" of science and humanity.